Defining High Risk of Osteoporotic Fracture A Cross Talk Between Clinical Experience and Guidelines Recommendations

被引:2
|
作者
Casado, Enrique [1 ,2 ]
Malouf, Jorge [3 ]
Caamano, Manuel M. [4 ]
Salas, Esteban [5 ]
Sanchez-Burson, Juan M. [6 ]
Rentero, Maria L. [7 ]
Herrero-Beaumont, Gabriel [8 ]
机构
[1] Corp Sanitaria, Hosp Sabadell, Dept Rheumatol, Barcelona 08208, Spain
[2] Univ Parc Tauli, Barcelona 08208, Spain
[3] Hosp Santa Creu & Sant Pau, Dept Internal Med, Barcelona, Spain
[4] Hosp Clin Univ Santiago de Compostela, Dept Rheumatol, Galicia, Spain
[5] Hosp Univ San Juan de Alicante, Dept Rheumatol, Alicante, Spain
[6] Hosp Univ Nuestra Senora de Valme, Dept Rheumatol, Seville, Spain
[7] Dept Med, Bone Metab Unit, Lilly, Spain
[8] Fdn Jimenez Diaz, Dept Rheumatol, E-28040 Madrid, Spain
关键词
fracture; health care survey; high risk; osteoporosis; risk factors; BONE-MINERAL DENSITY; POSTMENOPAUSAL WOMEN; SUBSEQUENT FRACTURE; METAANALYSIS; BMD; MANAGEMENT; DIAGNOSIS; OUTCOMES; QUALITY; BURDEN;
D O I
10.1097/RHU.0b013e318227a106
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: There is no universally accepted definition for patients at high risk of osteoporotic fracture. Objectives: This study aimed to survey Spanish rheumatologists; to obtain opinions about risk factors, and an acceptable definition for patients at high risk of osteoporotic fracture; and to compare daily practice patterns with current osteoporosis guidelines. Methods: A total of 174 rheumatologists from throughout Spain completed an online survey about various risk factors for fragility fracture and about the management of patients with osteoporosis in clinical practice. Results were reviewed by a coordinating committee of osteoporosis experts and were compared with published national and international guideline recommendations. Results: Almost all rheumatologists who completed the survey (99%) consider that a group of patients exists with a high risk of osteoporotic fracture and that this group should be managed appropriately. Previous fracture is considered the most important risk factor, particularly in cases of multiple fracture, severe vertebral fracture; hip fracture, or fracture despite osteoporosis treatment. However, in osteoporosis guidelines, age, bone mineral density, and previous fragility fracture are the most important risk factors for new fracture. Furthermore, Spanish rheumatologists tend to treat patients at high risk of fracture with anabolic therapy (e.g., teriparatide), whereas guidelines make no such recommendation. Conclusions: In osteoporosis, a large gap exists between implementation of guideline recommendations and actual clinical practice; this may be due, in part, to heterogeneity among existing guidelines. Thus, inclusion in guidelines of a practical definition of high risk of osteoporotic fracture,may provide significant opportunities to improve patient care and prevent future fragility fractures.
引用
收藏
页码:S59 / S66
页数:8
相关论文
共 50 条
  • [11] The association between 10-year fracture risk by FRAX and osteoporotic fractures with disease activity in patients with rheumatoid arthritis
    Phuan-udom, Ratanapha
    Lektrakul, Nittaya
    Katchamart, Wanruchada
    CLINICAL RHEUMATOLOGY, 2018, 37 (10) : 2603 - 2610
  • [12] A biomechanical sorting of clinical risk factors affecting osteoporotic hip fracture
    Luo, Y.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 (02) : 423 - 439
  • [13] Clinical Characteristics of Elderly People with Osteoporotic Vertebral Compression Fracture Based on a 12-Year Single-Center Experience in Korea
    Lee, Seung-Kwan
    Jun, Deuk-Soo
    Lee, Dong-Keun
    Baik, Jong-Min
    GERIATRICS, 2022, 7 (06)
  • [14] Effect of abaloparatide on vertebral, nonvertebral, major osteoporotic, and clinical fractures in a subset of postmenopausal women at increased risk of fracture by FRAX probability
    McCloskey, E. V.
    Fitzpatrick, L. A.
    Hu, M. -Y.
    Williams, G.
    Kanis, J. A.
    ARCHIVES OF OSTEOPOROSIS, 2019, 14 (01)
  • [15] How Good is Our Best Guess? Clinical Application of the WHO FRAX Tool in Osteoporotic Fracture Risk Determination and Treatment Decisions
    Hinz, Laura
    Freiheit, Elizabeth
    Kline, Gregory
    CALCIFIED TISSUE INTERNATIONAL, 2016, 99 (02) : 114 - 120
  • [16] Analysis of chosen clinical risk factors of osteoporotic fracture
    Marcinkowska, Michalina
    Wawrzyniak, Anna
    Ignaszak-Szczepaniak, Magdalena
    Bryl, Nadia
    Horst-Sikorska, Wanda
    FAMILY MEDICINE AND PRIMARY CARE REVIEW, 2008, 10 (03) : 498 - 500
  • [17] ASSESSMENT OF OSTEOPOROTIC FEMORAL FRACTURE RISK: FINITE ELEMENT METHOD AS A POTENTIAL REPLACEMENT FOR CURRENT CLINICAL TECHNIQUES
    van den Munckhof, Sven
    Nikooyan, Ali Asadi
    Zadpoor, Amir Abbas
    JOURNAL OF MECHANICS IN MEDICINE AND BIOLOGY, 2015, 15 (03)
  • [18] Were you identified to be at high fracture risk by FRAXA® before your osteoporotic fracture occurred?
    Chen, Xiao-feng
    Li, Xiao-lin
    Zhang, Hui
    Liu, Ge-jun
    CLINICAL RHEUMATOLOGY, 2014, 33 (05) : 693 - 698
  • [19] Clinical risk factors for fracture in postmenopausal osteoporotic women: A review of the recent literature
    LaFleur, Joanne
    McAdam-Marx, Carrie
    Kirkness, Carmen
    Brixner, Diana I.
    ANNALS OF PHARMACOTHERAPY, 2008, 42 (03) : 375 - 386
  • [20] Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX
    McCloskey, Eugene V.
    Johansson, Helena
    Oden, Anders
    Austin, Matt
    Siris, Ethel
    Wang, Andrea
    Lewiecki, E. Michael
    Lorenc, Roman
    Libanati, Cesar
    Kanis, John A.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (07) : 1480 - 1486